TECTONIC THERAPEUTIC, INC. Accrued Liabilities, Current
TECTONIC THERAPEUTIC, INC. (TECX) had Accrued Liabilities, Current of $7.11 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities, Current $7.11M.
- 2026-03-31: Accrued Liabilities, Current $8.97M.
- 2025-12-31: Accrued Liabilities, Current $7.34M.
- 2025-09-30: Accrued Liabilities, Current $6.75M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $7.11M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $8.97M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $7.34M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $6.75M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $6.80M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $4.91M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $7.85M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $12.74M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $20.01M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $3.04M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $8.14M 10-K · filed 2025-03-20 | $5.45M 10-K · filed 2024-03-14 |
| 2023-09-30 | $5.00M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $8.34M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $11.08M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $11.73M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $14.33M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $12.57M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $12.88M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $15.64M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $19.56M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $14.66M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $9.82M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $13.69M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $22.52M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $12.79M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $10.64M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $9.85M 10-K · filed 2021-03-18 | $10.07M 10-K · filed 2020-03-16 |
| 2019-09-30 | $8.50M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $6.19M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $6.48M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $7.82M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $3.85M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $5.44M 10-Q · filed 2018-08-09 | |
| 2017-12-31 | $2.10M 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |